Benzinga | Nov 6, 2020 06:35AM EST

Epizyme Q3 EPS $(0.55) Beats $(0.60) Estimate, Sales $3.60M Miss $5.43M Estimate

Epizyme (NASDAQ:EPZM) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.60) by 8.33 percent. This is a 37.5 percent decrease over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $3.60 million which missed the analyst consensus estimate of $5.43 million by 33.70 percent. This is a 37.01 percent decrease over sales of $5.71 million the same period last year.